[Smile]_老虎社区_美港股上老虎

2021-11-22

[Smile]

iSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen股价早盘大涨超140%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":875963727,"tweetId":"875963727","gmtCreate":1637594912596,"gmtModify":1637594912716,"author":{"id":3572319379588082,"idStr":"3572319379588082","authorId":3572319379588082,"authorIdStr":"3572319379588082","name":"Jessemyne","avatar":"https://static.tigerbbs.com/6252e2c2d2486e6000e4f9a349488762","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>[Smile]&nbsp; </body></html>","htmlText":"<html><head></head><body>[Smile]&nbsp; </body></html>","text":"[Smile]","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/875963727","repostId":1121185868,"repostType":4,"repost":{"id":"1121185868","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637592275,"share":"https://www.laohu8.com/m/news/1121185868?lang=zh_CN&edition=full","pubTime":"2021-11-22 22:44","market":"us","language":"en","title":"iSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen股价早盘大涨超140%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1121185868","media":"Tiger Newspress","summary":"iSpecimen shares surged more than 140% in early trading.iSpecimen Inc.(Nasdaq: ISPC), an online mark","content":"iSpecimen&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;140%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/004231075c27a5023d82afda7d30605e\" tg-width=\"865\" tg-height=\"597\" width=\"100%\" height=\"auto\"><a href=\"https://laohu8.com/S/ISPC\">iSpecimen Inc.</a>(Nasdaq: ISPC), an online marketplace forhuman biospecimens, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.<blockquote>iSpecimen股价早盘飙升逾140%。<a href=\"https://laohu8.com/S/ISPC\">iSpecimen公司。</a>（纳斯达克：ISPC），在线市场人体生物样本今天宣布，它已签约支持关于COVID-19的新的高级研究，以寻求对其在多个人群中的传播性、变异、结果和测试有效性的见解。在过去的十个月里，该公司与多个研究和医疗保健组织合作开展了一系列不同的项目，这些项目需要各种新冠肺炎样本，包括鼻拭子、唾液和血液制品。</blockquote> The Company's work on COVID-19 began immediately after the outbreak last year when it began&nbsp;sending serum samples to the U.S. Centers for Disease Control and Prevention&nbsp;to help&nbsp;researchers monitor antibody development for possible guidance on immunity. iSpecimen provided the Centers for Disease Control and Prevention (\"CDC\") with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples, mostly remnants from lab tests.<blockquote>该公司在新冠肺炎方面的工作在去年疫情爆发后立即开始，当时它开始向美国疾病控制和预防中心发送血清样本，以帮助研究人员监测抗体的发展，以获得可能的免疫指导。iSpecimen向疾病控制和预防中心（“CDC”）提供了600份新型冠状病毒阳性血清样本和100份阴性血清样本，大部分是实验室测试的残余物。</blockquote> In addition, iSpecimen has been contracted by other federal agencies and private companies for custom COVID-19 collections, which are often complex and complement the more immediate availability of remnant or banked samples.<blockquote>此外，iSpecimen还与其他联邦机构和私营公司签订了定制新冠肺炎采集合同，这些采集通常很复杂，可以补充更直接的剩余或库存样本。</blockquote> \"COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society's ability to contend with future outbreaks of infectious diseases,\" said&nbsp;iSpecimen Founder and CEO,Christopher Ianelli, MD, Ph.D. \"We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they're focusing on.\"<blockquote>iSpecimen创始人兼首席执行官Christopher Ianelli医学博士表示：“COVID-19已夺去了超过500万人的生命，需要进行大量额外的研究来控制这一流行病并提高社会应对未来传染病爆发的能力。”“我们接受这一挑战，并很高兴研究人员向我们寻求他们所关注的患者类型所需的特定生物样本。”</blockquote> COVID-Related Research<blockquote>COVID相关研究</blockquote> In addition to the work iSpecimen has done with the CDC, iSpecimen has recently supplied hundreds of human biospecimens to ongoing COVID-19 research being conducted by&nbsp;the United Statesmilitary. The specimens, including positive SARS-CoV-2 samples and negative controls, help researchers validate COVID-19 testing platforms, understand fluctuations in patients' antibody levels, monitor contagion among close contacts, and more.<blockquote>除了iSpecimen与CDC所做的工作之外，iSpecimen最近还向美国军方正在进行的COVID-19研究提供了数百份人类生物样本。这些样本包括阳性新型冠状病毒样本和阴性对照，有助于研究人员验证COVID-19检测平台、了解患者抗体水平的波动、监测密切接触者之间的传染等。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen股价早盘大涨超140%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen股价早盘大涨超140%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nTiger Newspress \n2021-11-22 22:44\n</div>\n</a>\n</h4>\n</header>\n<article>\niSpecimen&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;140%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/004231075c27a5023d82afda7d30605e\" tg-width=\"865\" tg-height=\"597\" width=\"100%\" height=\"auto\"><a href=\"https://laohu8.com/S/ISPC\">iSpecimen Inc.</a>(Nasdaq: ISPC), an online marketplace forhuman biospecimens, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.<blockquote>iSpecimen股价早盘飙升逾140%。<a href=\"https://laohu8.com/S/ISPC\">iSpecimen公司。</a>（纳斯达克：ISPC），在线市场人体生物样本今天宣布，它已签约支持关于COVID-19的新的高级研究，以寻求对其在多个人群中的传播性、变异、结果和测试有效性的见解。在过去的十个月里，该公司与多个研究和医疗保健组织合作开展了一系列不同的项目，这些项目需要各种新冠肺炎样本，包括鼻拭子、唾液和血液制品。</blockquote> The Company's work on COVID-19 began immediately after the outbreak last year when it began&nbsp;sending serum samples to the U.S. Centers for Disease Control and Prevention&nbsp;to help&nbsp;researchers monitor antibody development for possible guidance on immunity. iSpecimen provided the Centers for Disease Control and Prevention (\"CDC\") with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples, mostly remnants from lab tests.<blockquote>该公司在新冠肺炎方面的工作在去年疫情爆发后立即开始，当时它开始向美国疾病控制和预防中心发送血清样本，以帮助研究人员监测抗体的发展，以获得可能的免疫指导。iSpecimen向疾病控制和预防中心（“CDC”）提供了600份新型冠状病毒阳性血清样本和100份阴性血清样本，大部分是实验室测试的残余物。</blockquote> In addition, iSpecimen has been contracted by other federal agencies and private companies for custom COVID-19 collections, which are often complex and complement the more immediate availability of remnant or banked samples.<blockquote>此外，iSpecimen还与其他联邦机构和私营公司签订了定制新冠肺炎采集合同，这些采集通常很复杂，可以补充更直接的剩余或库存样本。</blockquote> \"COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society's ability to contend with future outbreaks of infectious diseases,\" said&nbsp;iSpecimen Founder and CEO,Christopher Ianelli, MD, Ph.D. \"We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they're focusing on.\"<blockquote>iSpecimen创始人兼首席执行官Christopher Ianelli医学博士表示：“COVID-19已夺去了超过500万人的生命，需要进行大量额外的研究来控制这一流行病并提高社会应对未来传染病爆发的能力。”“我们接受这一挑战，并很高兴研究人员向我们寻求他们所关注的患者类型所需的特定生物样本。”</blockquote> COVID-Related Research<blockquote>COVID相关研究</blockquote> In addition to the work iSpecimen has done with the CDC, iSpecimen has recently supplied hundreds of human biospecimens to ongoing COVID-19 research being conducted by&nbsp;the United Statesmilitary. The specimens, including positive SARS-CoV-2 samples and negative controls, help researchers validate COVID-19 testing platforms, understand fluctuations in patients' antibody levels, monitor contagion among close contacts, and more.<blockquote>除了iSpecimen与CDC所做的工作之外，iSpecimen最近还向美国军方正在进行的COVID-19研究提供了数百份人类生物样本。这些样本包括阳性新型冠状病毒样本和阴性对照，有助于研究人员验证COVID-19检测平台、了解患者抗体水平的波动、监测密切接触者之间的传染等。</blockquote>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISPC":"iSpecimen Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121185868","content_text":"iSpecimen shares surged more than 140% in early trading.iSpecimen Inc.(Nasdaq: ISPC), an online marketplace forhuman biospecimens, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.\nThe Company's work on COVID-19 began immediately after the outbreak last year when it began sending serum samples to the U.S. Centers for Disease Control and Prevention to help researchers monitor antibody development for possible guidance on immunity. iSpecimen provided the Centers for Disease Control and Prevention (\"CDC\") with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples, mostly remnants from lab tests.\nIn addition, iSpecimen has been contracted by other federal agencies and private companies for custom COVID-19 collections, which are often complex and complement the more immediate availability of remnant or banked samples.\n\"COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society's ability to contend with future outbreaks of infectious diseases,\" said iSpecimen Founder and CEO,Christopher Ianelli, MD, Ph.D. \"We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they're focusing on.\"\nCOVID-Related Research\nIn addition to the work iSpecimen has done with the CDC, iSpecimen has recently supplied hundreds of human biospecimens to ongoing COVID-19 research being conducted by the United Statesmilitary. The specimens, including positive SARS-CoV-2 samples and negative controls, help researchers validate COVID-19 testing platforms, understand fluctuations in patients' antibody levels, monitor contagion among close contacts, and more.","news_type":1,"symbols_score_info":{"ISPC":0.9}},"isVote":1,"tweetType":1,"viewCount":2553,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/875963727"}